- Conditions
- Smallpox, Anthrax
- Interventions
- BioCASES and BioTESTS
- Behavioral
- Lead sponsor
- US Department of Veterans Affairs
- Federal
- Eligibility
- Not listed
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2007
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Loma Linda, California + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Anthrax
- Interventions
- BioThrax
- Biological
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 4
- States / cities
- Miami, Florida • Rochester, New York • Mt. Pleasant, South Carolina + 1 more
- Conditions
- Infections, Bacterial
- Interventions
- AVA, Raxibacumab, Diphenhydramine
- Biological · Drug
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 573 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 3
- States / cities
- Edgewater, Florida • Overland Park, Kansas • Knoxville, Tennessee
- Conditions
- Bacillus Anthracis (Anthrax)
- Interventions
- Anthrax vaccine absorbed made from Bacillus anthracis (AVA), Recombinant protein antigen (rPA) made from Bacillus anthrax, Recombinant protein antigen (rPA) made from Escherichia coli
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 270 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Ends 2007
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland • Durham, North Carolina
- Conditions
- Anthrax
- Interventions
- AV7909, BioThrax
- Biological
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 168 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 4
- States / cities
- Miami, Florida • Mt. Pleasant, South Carolina • New Braunfels, Texas + 1 more
- Conditions
- Bacillus Anthracis (Anthrax)
- Interventions
- BioThrax®
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 328 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 4
- States / cities
- Atlanta, Georgia • Cincinnati, Ohio • Houston, Texas + 1 more
- Conditions
- Healthy Volunteers
- Interventions
- NasoShield, Placebo
- Biological · Other
- Lead sponsor
- Altimmune, Inc.
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 43 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Healthy
- Interventions
- Anthrax Vaccine Adsorbed, Saline injection
- Biological
- Lead sponsor
- Centers for Disease Control and Prevention
- Federal
- Eligibility
- 18 Years to 61 Years
- Enrollment
- 1,564 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2002 – 2010
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Atlanta, Georgia • Silver Spring, Maryland + 2 more
- Conditions
- Inhalational Anthrax
- Interventions
- ETI-204, Placebo
- Biological · Other
- Lead sponsor
- Elusys Therapeutics
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 280 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Ischemic Stroke, Malignant Edema
- Interventions
- Glyburide for Injection, Placebo
- Drug
- Lead sponsor
- Remedy Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 17
- States / cities
- Tucson, Arizona • Stanford, California • New Haven, Connecticut + 14 more
- Conditions
- Anthrax
- Interventions
- Normal Saline for Injection, MDX1303
- Drug · Biological
- Lead sponsor
- PharmAthene, Inc.
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Anthrax
- Interventions
- Anthrax, Alhdryogel or PBS
- Biological
- Lead sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Industry
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2004
- U.S. locations
- 1
- States / cities
- Rockville, Maryland
- Conditions
- Anthrax Infection
- Interventions
- AVA, Ad4-PA-1, Ad4-PA-GPI-1
- Biological
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years to 40 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 4
- States / cities
- Kansas City, Kansas • Silver Spring, Maryland • St Louis, Missouri + 1 more
- Conditions
- Anthrax
- Interventions
- rPA102
- Biological
- Lead sponsor
- VaxGen
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 480 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2005
- U.S. locations
- 12
- States / cities
- Torrance, California • Atlanta, Georgia • Lexington, Kentucky + 9 more
- Conditions
- Anthrax, Bacillus Infections
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 3 Years to 100 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2002
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Bacillus Anthracis (Anthrax) Infection
- Interventions
- BioThrax, AV7909 Formulation 1, AV7909 Formulation 2, AV7909 Formulation 3, AV7909 Formulation 4, Control
- Biological · Drug
- Lead sponsor
- Emergent BioSolutions
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 105 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2012
- U.S. locations
- 3
- States / cities
- Miami, Florida • Raleigh, North Carolina • Salt Lake City, Utah
- Conditions
- Bacillus Anthracis (Anthrax)
- Interventions
- AVA, rPA vaccine containing alhydrogel
- Biological
- Lead sponsor
- PharmAthene UK Limited
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 226 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2007
- U.S. locations
- 16
- States / cities
- Huntsville, Alabama • Mobile, Alabama • San Diego, California + 12 more
- Conditions
- Anthrax
- Interventions
- BW-1010: 50 µg - sprayer - IN, BW-1010: 50 µg - pipette - IN, BW-1010: 100 µg - sprayer - IN, BW-1010: 100 µg - pipette - IN, Saline (Placebo) - sprayer - IN, Saline (Placebo) - pipette - IN, BioThrax (positive control) - SC
- Biological
- Lead sponsor
- BlueWillow Biologics
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Lenexa, Kansas
- Conditions
- Neoplasms, Malignant, Breast Neoplasm, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasm, Head and Neck Neoplasms
- Interventions
- Carlo Erba Ink Injection, EPR Oximetry Measurement
- Device · Other
- Lead sponsor
- Philip Schaner
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Anthrax
- Interventions
- Px563L, RPA563, or placebo
- Biological
- Lead sponsor
- Pfenex, Inc
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Inhalational Anthrax
- Interventions
- ETI-204, Placebo
- Biological · Other
- Lead sponsor
- Elusys Therapeutics
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 2
- States / cities
- Overland Park, Kansas • Minneapolis, Minnesota
- Conditions
- Febrile Infection, Anthrax
- Interventions
- TaqMan Bacillus anthracis Detection Kit
- Device
- Lead sponsor
- MRI Global
- Industry
- Eligibility
- 2 Years to 89 Years
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 3
- States / cities
- Tarpon Springs, Florida • Fall River, Massachusetts • Franklin, Massachusetts
- Conditions
- Smoking ( Cigarette)
- Interventions
- Charcoal filtered cigarettes with marketing, Charcoal filtered cigarette without marketing, Non-charcoal filtered cigarettes
- Behavioral
- Lead sponsor
- Rutgers, The State University of New Jersey
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 252 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- New Brunswick, New Jersey
- Conditions
- Bacillus Anthracis (Anthrax)
- Interventions
- Ciprofloxacin 500 mg, ETI-204 (Anthim)
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Columbus, Ohio